An epinephrine auto-injector developed by an innovative U.Va. alumnus is now available in U.S. pharmacies.
Evan Edwards (Mechanical Engineering ’02, Systems Engineering ’04) and twin brother Eric are the founders of Richmond-based Intelliject Inc. Both sufferers of severe allergies, they combined their respective engineering and medical educations to develop an improved epinephrine self-injector for the treatment of severe allergic reactions, such as those affecting more than 6 million people at risk for anaphylaxis in the U.S.
Their product, Auvi-Q™, is about the size of a credit card, has a self-retractable needle, and provides audible instructions and visual cues for self-administration. Intelliject licensed Auvi-Q™ to Sanofi North America pharmaceuticals for commercialization in the U.S. It is now available at thousands of U.S. pharmacies with a doctor’s prescription.
- Richmond company’s allergy device on sale at U.S. pharmacies (Richmond Times-Dispatch, 01/29/13)
- Auvi-Q™ is now available in the U.S. (Press release, 01/28/13)